©2026 Bryn Mawr Communications, LLC.
All Rights Reserved

Terms and Conditions • Privacy Policy
Look at the Lids

Meibomian Gland Structure and Function in Patients with Demodex blepharitis

Cecelia Koetting, OD, FAAO

Show Description +

Cecelia Koetting, OD, FAAO, reviews a study evaluating how structural and functional measures of meibomian gland dysfunction compare in patients in eyes with moderate to severe Demodex blepharitis compared to those with collarette grade 0. Dr. Koetting shares the parameters of the study, key findings, and what this might mean for clinical practice. Dr. Koetting is a paid consultant for Tarsus Pharmaceuticals Inc. Sponsored by Tarsus Pharmaceuticals, Inc.

Posted: 4/01/2026

Up Next

Prevalence of <i>Demodex</i> Blepharitis
Prevalence of Demodex Blepharitis

Sumitra S. Khandelwal, MD; Eric D. Rosenberg, DO; Neda Shamie, MD; Christopher E. Starr, MD; Nandini Venkateswaran, MD

Prevalence and Diagnosis of Demodex Blepharitis

Prevalence of <i>Demodex</i> Blepharitis
Prevalence of Demodex Blepharitis

Sumitra S. Khandelwal, MD; Eric D. Rosenberg, DO; Neda Shamie, MD; Christopher E. Starr, MD; Nandini Venkateswaran, MD

Diagnosing <i>Demodex</i> Blepharitis
Diagnosing Demodex Blepharitis

Sumitra S. Khandelwal, MD; Eric D. Rosenberg, DO; Neda Shamie, MD; Christopher E. Starr, MD; Nandini Venkateswaran, MD

Up Close with Demodex Blepharitis

Pathology of <i>Demodex</i> Blepharitis
Pathology of Demodex Blepharitis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Prevalence and Characterization
Prevalence and Characterization

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Risk Factors and Comorbidities
Risk Factors and Comorbidities

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Diagnosis
Diagnosis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Clinical Impact of <i>Demodex</i> Blepharitis
Clinical Impact of Demodex Blepharitis

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

<i>Demodex</i> Blepharitis Co-Management
Demodex Blepharitis Co-Management

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Elevating <i>Demodex</i> Blepharitis As Part Of Eyelid Health
Elevating Demodex Blepharitis As Part Of Eyelid Health

Blake Williamson, MD, MPH; Joshua Davidson, OD, FAAO, FSLS

Demodex Blepharitis Prevalence, Impact, and Diagnosis

An Overview of <i>Demodex </i> Blepharitis
An Overview of Demodex Blepharitis

Impact of <i>Demodex</i> Blepharitis on Patients and Healthcare System: Results from the Atlas Continuation Study
Impact of Demodex Blepharitis on Patients and Healthcare System: Results from the Atlas Continuation Study

Blake Simmons, OD

The Real-World Prevalence of Collarettes and <i>Demodex</i> Blepharitis in Eye Care Practices
The Real-World Prevalence of Collarettes and Demodex Blepharitis in Eye Care Practices

Ehsan Sadri, MD, FACS

Psychosocial Impact of <i>Demodex</i> Blepharitis
Psychosocial Impact of Demodex Blepharitis

Elizabeth Yeu, MD

Overview of Clinical Manifestations of <i>Demodex</i> Blepharitis
Overview of Clinical Manifestations of Demodex Blepharitis

Scott Schachter, OD

link-arrow   Back to All Videos

Meibomian Gland Structure and Function in Patients with Demodex blepharitis

Cecelia Koetting, OD, FAAO

Cecelia Koetting, OD, FAAO, reviews a study evaluating how structural and functional measures of meibomian gland dysfunction compare in patients in eyes with moderate to severe Demodex blepharitis compared to those with collarette grade 0. Dr. Koetting shares the parameters of the study, key findings, and what this might mean for clinical practice. Dr. Koetting is a paid consultant for Tarsus Pharmaceuticals Inc. Sponsored by Tarsus Pharmaceuticals, Inc.

Posted: 4/01/2026

About Look at the Lids

While ~58% of eye care patients may have Demodex blepharitis (DB), it is often missed or misdiagnosed.1 Discover how to spot DB in your practice.

Visit us online: lookatthelids.com

Contact Us

Follow Look at the Lids